To include your compound in the COVID-19 Resource Center, submit it here.

Adolor, GlaxoSmithKline deal

Adolor will regain full U.S. rights from GlaxoSmithKline to Entereg alvimopan to treat postoperative ileus (POI).

Read the full 162 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE